glp 1 zepbound FDA approval for (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Wegovy and Zepbound just got
Description
Patients taking semaglutide typically experience reductions in fasting plasma glucose and HbA1c levels
Initial research has found that these medications may improve outcomes in people with conditions ranging from sleep apnea and fatty liver disease to heart and kidney disease
doi: 10.1080/14656566.2020.1795132, PMID: [DOI] [PubMed] [Google Scholar] 85
Are compounded GLP-1 drugs as safe as brand-name versions
